COVID-19 roadmap for reopening could lead to a third wave in England
The current roadmap out of lockdown for England could lead to an extra 15,700 deaths by next summer, according to Imperial's latest modelling.
Coronavirus infections levelling off in England - REACT study
The rate of new coronavirus infections has levelled off with 1 in 500 people currently infected in England.
New national study of long-term impacts of lung damage from COVID-19
A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19.
National drug trial to prevent deaths after COVID-19 patients leave hospital
UK-wide study launching to reduce the number of people who die in the months following a stay in hospital with COVID-19.
Global trial reports on use of tocilizumab in COVID-19 pneumonia
The anti-inflammatory treatment tocilizumab does not significantly improve outcomes for patients with severe COVID-19 pneumonia, a trial has found.
First volunteers on COVID-19 human challenge study leave quarantine
The UK’s COVID-19 human challenge study has reached its first milestone after administering virus to three volunteers in a controlled clinical setting
COVID-19 vaccine hesitancy could lead to thousands of extra deaths
Hesitancy around COVID-19 vaccines could lead to thousands of extra deaths over a two-year period, Imperial epidemiologists show.
Audio
Podcast: COVID-19 human trials, air pollution monitoring and better plastics
In this edition: Launching human challenge trials for COVID-19, a new air pollution monitoring network for London, and fully biodegradable plastics.
Imperial Covid-19 Response Team: A year tracking the global pandemic
Imperial's COVID-19 Response Team has spent over a year tracking the trajectory of the coronavirus pandemic.
‘Disastrous’ consequences of cuts to global science collaboration, warn experts
Experts have emphasised the value of international collaborative science and the need for its long-term financial security.
